The introduction and the optimization of an alpha-amino substituent based on a series of alpha-hydroxy-beta-N-biaryl ether sulfonamide hydroxamates is described. The modification leads to a new series of MMP-2/MMP-9 inhibitors with enhanced inhibitory activities and improved ADME properties. An efficacy study on reducing the ischemia-induced brain edema in the rat transient middle cerebral artery occlusion (tMCAo) model is also demonstrated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2007.11.129 | DOI Listing |
Publication Analysis
Top Keywords
ether sulfonamide
8
sulfonamide hydroxamates
8
optimization alpha-amino
8
beta-n-biaryl ether
4
hydroxamates potent
4
potent gelatinase
4
gelatinase inhibitors
4
inhibitors optimization
4
alpha-amino substituents
4
substituents introduction
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!